Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

iRobot

UiPath

Robotics does not necessarily have to look like in the movies, where you have a janitor in the house who makes your meals, washes your dishes, and brings your coffee to bed every morning. Robotics is also manifested in areas such as medicine, data interpretation, and of course in tools that facilitate our daily lives, either in our jobs or our homes.

3 Unstoppable Robotics Stocks That Will Make Early Investors Rich

Here is how Intuitive Surgical, Inc. (ISRG) and Artivion (AORT) have performed compared to their sector so far this year.

Is Intuitive Surgical (ISRG) Stock Outpacing Its Medical Peers This Year?

Medpace Holdings

Transmedics Group Inc

Intuitive Surgical's 80% market share and razor-and-blade model deserve a premium valuation. TransMedics is not only an easy stock to root for but is in hyper-growth mode and nearing profitability.

3 Best Stocks to Buy With $300 Right Now

Amazon

Many investors are hoping that the stock market is at an inflection point. Amazon is recovering from the doldrums of macroeconomic woes and is raking in cash and profits once more.

2 Top Growth Stocks Up 50% and 10% to Buy Whether a 2023 Bull Market Happens or Not

Southern Company

Essential Utilities

Intuitive Surgical's growth is just beginning. Southern Company is a very safe utility stock with a high yield.

3 Recession-Resistant Stocks to Buy Now

Intuitive Surgical's capital allocation has underperformed in recent years, but with no debt, the ROIC-WACC spread is still excellent. However, the EV/EBIT multiple is too high and robs new investors of much of the future returns if they invest now. Buying at a 20-25x multiple may be a better long-term investment strategy if your goal is a 15%+ CAGR.

Intuitive Surgical: Company Has Everything You Could Want, Except For One Thing

Moderna

UnitedHealth Group

According to the American Medical Association, U.S. healthcare spending totaled $4.3 trillion in 2021, equal to nearly $13,000 per person. Overall medical expenses account for nearly 20% of U.S. gross domestic product (GDP).

Don't Miss the Boom: 3 Healthcare Stocks Set to Explode Higher

Apple

Bruker

Chipotle

Datadog

DraftKings

HubSpot

KLA-Tencor

Lockheed Martin

Lam Research

Las Vegas Sands

MongoDB

Netflix

NVIDIA

Paycom Software

Pinterest

Insulet

Rockwell Automation

Teradata

TKO Group Holdings Inc

Citi has released a list of 20 large-cap growth stocks that it says present opportunities in the event of a pullback.

These 20 growth stocks are worth considering on a pullback, says Citi

Chipotle, Draftkings, Lam Research and eight other stocks may be underappreciated by investors, according to a screen run by Citi analysts.

11 Beaten-Up Growth Stocks That Look Like Buys, Says Citi

Toyota Motor

Zebra Technologies

While the capital markets buzz with possibilities, few sectors incite as much excitement as top robotics stocks. Automation, innovation and the tantalizing promise of ushering in a new era of productivity have fueled much of this fervor.

3 Robotics Stocks That Should Be on Every Investor's Radar This Fall

Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.

3 Reasons to Add Intuitive Surgical (ISRG) to Your Portfolio

Medtronic

The artificial intelligence (AI) boom has taken the technology world by storm. However, this can benefit every sector and industry.

Why the market is excited about these two growth stocks?

Intuitive Surgical investors suffered a steep decline recently, even as Intuitive posted solid quarterly results but provided less robust guidance. As such, it left little room for disappointment. Concerns about China's tepid economic recovery and the impact on Intuitive's international growth momentum likely affected investors' sentiment. The recent worries about the impact from diabetic drugs on its weight loss procedures could have spooked the market further. Investors need to assess whether the impact could be structural.

Intuitive Surgical: Plunged 20% To August Lows - Why I'm Still Not Convinced

Entegris

Trade Desk

According to Federal Reserve data, the United States household wealth reached a record high of $154.3 trillion during Q2 2023. This development carries substantial significance for the stock market.

The 3 Most Undervalued Nasdaq Stocks to Buy in September 2023

Delta Air Lines

JD.com

Cheniere Energy

McDonald's

Mondelez

Stellantis N.V. 

Generally, onlookers dismiss large-cap stocks to buy as the arena for ultra-conservative investors; you know, the type that mimics Warren Buffett's every move. There's absolutely nothing wrong with that.

7 Large-Cap Stocks With Surprisingly Robust Upside Potential

Shopify

E-commerce and healthcare spending are projected to grow significantly in the years ahead. Shopify is capitalizing on the AI boom and just entered a game-changing partnership with an e-commerce giant.

Have $1,500 to Invest? 2 Growth Stocks to Buy Now

Johnson & Johnson

Pfizer

Teladoc

In today's dynamic market, many investors are paying attention to the healthcare sector. The segment is known for its resilience and potential for growth.

The 5 Best Healthcare Stocks to Buy Now: September 2023

DexCom

We believe DexCom stock (NASDAQ: DXCM) is a better healthcare pick than Intuitive Surgical stock (NASDAQ: ISRG).

With 2x Potential Returns Is DexCom A Better Pick Over Intuitive Surgical?

Despite bouncing 42% (year-to-date) through the end of August, the Nasdaq 100 still sits 7% below its all-time high. Two Nasdaq 100 components have well-defined moats within their specific industries that should cultivate a sustained double-digit growth rate.

2 Nasdaq 100 Stocks That Are Surefire Buys in September and 1 to Avoid Like the Plague

ExScientia Ltd

GE HealthCare Technologies Inc

Med tech stocks are ripe for growth due to the advent of artificial intelligence ( AI ). AI is going to improve healthcare overall.

3 Med Tech Stocks That the AI Boom Will Only Help

Intuitive Surgical, Inc. (NASDAQ:ISRG ) 2023 Wells Fargo Healthcare Conference Transcript September 7, 2023 3:00 PM ET Executives Jamie Samath - Senior Vice President and CFO Brian King - Treasurer and Head, Investor Relations Analysts Larry Biegelsen - Wells Fargo Larry Biegelsen Good afternoon. I am Larry Biegelsen, the Medical Device Analyst at Wells Fargo and it's my pleasure to host this session with Intuitive Surgical.

Intuitive Surgical, Inc. (ISRG) Management Presents at 2023 Wells Fargo Healthcare Conference (Transcript)

Symbotic Inc

Technological advancements have expanded our capabilities. These developments enable higher productivity, quicker access to information, and new solutions to long-standing problems.

3 Up-and-Coming Robotics Stocks to Put on Your Must-Buy List

The 3 Most Promising Ray Dalio Stocks to Own Now

AbbVie

Baxter

Stryker

Med tech has been on the skids for no fault of its own. It's not the industry's fault that price action was driven to a frothy bubble by COVID-inspired trading outlooks or that the market has normalized.

A Significant Reversal is in Sight for These 5 Med Tech Companies

News for Intuitive Surgical Stock (ISRG)